Recommending revised hepatoblastoma surveillance in children with a pathogenic ARID1A variant. Reply to "Cancer in ARID1A-Coffin-Siris syndrome: Review and report of a child with hepatoblastoma" by Cárcamo et al. 2022

Affiliations

¹ Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Division of Medical Genetics and Metabolism, Children's Hospital of the King's Daughters, Norfolk, VA, USA; Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
² Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Division of Medical Genetics and Metabolism, Children's Hospital of the King's Daughters, Norfolk, VA, USA; Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: G.W.E.Santen@LUMC.nl.

Comment

P J van der Sluijs et al. Eur J Med Genet. 2023 Feb.

. 2023 Feb;66(2):104694.

doi: 10.1016/j.ejmg.2022.104694. Epub 2022 Dec 31.

¹ Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Division of Medical Genetics and Metabolism, Children's Hospital of the King's Daughters, Norfolk, VA, USA; Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
² Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands; Division of Medical Genetics and Metabolism, Children's Hospital of the King's Daughters, Norfolk, VA, USA; Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA; Department of Pediatrics, Baylor College of Medicine, San Antonio, TX, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: G.W.E.Santen@LUMC.nl.

No abstract available

Comment on

"Cancer in ARID1A-Coffin-Siris syndrome: Review and report of a child with hepatoblastoma".
Cárcamo B, Masotto B, Baquero-Vaquer A, Ceballos-Saenz D, Zapata-Aldana E. Cárcamo B, et al. Eur J Med Genet. 2022 Nov;65(11):104600. doi: 10.1016/j.ejmg.2022.104600. Epub 2022 Aug 29. Eur J Med Genet. 2022. PMID: 36049608 Review.